Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)

Abroad (travel likely)Recruiting

Conditions

Chronic Migraine

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Jacqueline Dobson) · ContactHOPE@umich.edu · 734-763-8469

Study leads

Alexandre DaSilva, DDS, DMedSc
Principal Investigator
University of Michigan

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Laser Acupuncture for Chronic Migraine

Chronic Migraine

Abroad (travel likely)Recruiting

Taichung, Taiwan

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

Chronic Migraine · Episodic Migraine · Migraine

Abroad (travel likely)Recruiting

Busan, South Korea · Busan, South Korea

A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

Chronic Migraine in Children

Abroad (travel likely)RecruitingPHASE3

New Haven, United States · Stamford, United States

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine

Abroad (travel likely)RecruitingPHASE3

Huntsville, United States · Fayetteville, United States